Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 22


Intranasal nanoemulsion-based inactivated respiratory syncytial virus vaccines protect against viral challenge in cotton rats.

O'Konek JJ, Makidon P, Landers JJ, Cao Z, Malinczak CA, Pannu J, Sun J, Bitko V, Ciotti S, Hamouda T, Wojcinski ZW, Lukacs NW, Fattom A, Baker JR Jr.

Hum Vaccin Immunother. 2015 Aug 26:0. [Epub ahead of print]


Formulation, high throughput in vitro screening and in vivo functional characterization of nanoemulsion-based intranasal vaccine adjuvants.

Wong PT, Leroueil PR, Smith DM, Ciotti S, Bielinska AU, Janczak KW, Mullen CH, Groom JV 2nd, Taylor EM, Passmore C, Makidon PE, O'Konek JJ, Myc A, Hamouda T, Baker JR Jr.

PLoS One. 2015 May 11;10(5):e0126120. doi: 10.1371/journal.pone.0126120. eCollection 2015.


Intranasal immunization with W 80 5EC adjuvanted recombinant RSV rF-ptn enhances clearance of respiratory syncytial virus in a mouse model.

Passmore C, Makidon PE, O'Konek JJ, Zahn JA, Pannu J, Hamouda T, Bitko V, Myc A, Lukacs NW, Fattom A, Baker JR Jr.

Hum Vaccin Immunother. 2014;10(3):615-22. Epub 2013 Dec 10.


Nanoemulsion W805EC improves immune responses upon intranasal delivery of an inactivated pandemic H1N1 influenza vaccine.

Das SC, Hatta M, Wilker PR, Myc A, Hamouda T, Neumann G, Baker JR Jr, Kawaoka Y.

Vaccine. 2012 Nov 6;30(48):6871-7. doi: 10.1016/j.vaccine.2012.09.007. Epub 2012 Sep 16.


Management of genital warts in pregnancy.

Hamouda T, Freij MA, Saleh M.

Clin Exp Obstet Gynecol. 2012;39(2):242-4.


Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W805EC combined with approved seasonal influenza antigens.

Stanberry LR, Simon JK, Johnson C, Robinson PL, Morry J, Flack MR, Gracon S, Myc A, Hamouda T, Baker JR Jr.

Vaccine. 2012 Jan 5;30(2):307-16. doi: 10.1016/j.vaccine.2011.10.094. Epub 2011 Nov 8.


Primary ovarian choriocarcinoma presenting with acute abdomen mimicking an ectopic pregnancy.

Freij MA, Saleh H, Hamouda T, Raje G, Saleh M.

Eur J Gynaecol Oncol. 2011;32(4):425-6.


A novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without Th2 associated vaccine-enhanced disease.

Lindell DM, Morris SB, White MP, Kallal LE, Lundy PK, Hamouda T, Baker JR Jr, Lukacs NW.

PLoS One. 2011;6(7):e21823. doi: 10.1371/journal.pone.0021823. Epub 2011 Jul 15.


In vitro antibacterial activity of NB-003 against Propionibacterium acnes.

Pannu J, McCarthy A, Martin A, Hamouda T, Ciotti S, Ma L, Sutcliffe J, Baker JR Jr.

Antimicrob Agents Chemother. 2011 Sep;55(9):4211-7. doi: 10.1128/AAC.00561-11. Epub 2011 Jul 11.


Intranasal immunization of ferrets with commercial trivalent influenza vaccines formulated in a nanoemulsion-based adjuvant.

Hamouda T, Sutcliffe JA, Ciotti S, Baker JR Jr.

Clin Vaccine Immunol. 2011 Jul;18(7):1167-75. doi: 10.1128/CVI.00035-11. Epub 2011 May 4.


Efficacy, immunogenicity and stability of a novel intranasal nanoemulsion-adjuvanted influenza vaccine in a murine model.

Hamouda T, Chepurnov A, Mank N, Knowlton J, Chepurnova T, Myc A, Sutcliffe J, Baker JR.

Hum Vaccin. 2010 Jul;6(7):585-94.


Topical nanoemulsion therapy reduces bacterial wound infection and inflammation after burn injury.

Hemmila MR, Mattar A, Taddonio MA, Arbabi S, Hamouda T, Ward PA, Wang SC, Baker JR Jr.

Surgery. 2010 Sep;148(3):499-509. doi: 10.1016/j.surg.2010.01.001. Epub 2010 Mar 2.


NB-002, a novel nanoemulsion with broad antifungal activity against dermatophytes, other filamentous fungi, and Candida albicans.

Pannu J, McCarthy A, Martin A, Hamouda T, Ciotti S, Fothergill A, Sutcliffe J.

Antimicrob Agents Chemother. 2009 Aug;53(8):3273-9. doi: 10.1128/AAC.00218-09. Epub 2009 May 11.


Development of immune response that protects mice from viral pneumonitis after a single intranasal immunization with influenza A virus and nanoemulsion.

Myc A, Kukowska-Latallo JF, Bielinska AU, Cao P, Myc PP, Janczak K, Sturm TR, Grabinski MS, Landers JJ, Young KS, Chang J, Hamouda T, Olszewski MA, Baker JR Jr.

Vaccine. 2003 Sep 8;21(25-26):3801-14.


The fungicidal activity of novel nanoemulsion (X8W60PC) against clinically important yeast and filamentous fungi.

Myc A, Vanhecke T, Landers JJ, Hamouda T, Baker JR Jr.

Mycopathologia. 2002;155(4):195-201.


Prevention of influenza pneumonitis by sialic Acid-conjugated dendritic polymers.

Landers JJ, Cao Z, Lee I, Piehler LT, Myc PP, Myc A, Hamouda T, Galecki AT, Baker JR Jr.

J Infect Dis. 2002 Nov 1;186(9):1222-30. Epub 2002 Oct 8.


A rapid staining technique for the detection of the initiation of germination of bacterial spores.

Hamouda T, Shih AY, Baker JR Jr.

Lett Appl Microbiol. 2002;34(2):86-90.


A novel surfactant nanoemulsion with a unique non-irritant topical antimicrobial activity against bacteria, enveloped viruses and fungi.

Hamouda T, Myc A, Donovan B, Shih AY, Reuter JD, Baker JR Jr.

Microbiol Res. 2001;156(1):1-7.


A novel surfactant nanoemulsion with broad-spectrum sporicidal activity against Bacillus species.

Hamouda T, Hayes MM, Cao Z, Tonda R, Johnson K, Wright DC, Brisker J, Baker JR Jr.

J Infect Dis. 1999 Dec;180(6):1939-49.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk